Ligand Pharmaceuticals Incorporated (LGND) ownership: insiders 10% · institutions 94% · index and ETF funds 11% (13F 2026-03-31). Insider activity, 90 days: Routine (36 sales, 0 open-market buys). 4 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 2961923.00 | $591.35M | 14.9% | 2026-03-31 |
| Vanguard | 2108953.00 | $421.05M | 10.6% | 2026-03-31 |
| Janus Henderson | 1009891.00 | $201.62M | 5.1% | 2026-03-31 |
| Invesco | 823604.00 | $164.43M | 4.1% | 2026-03-31 |
| State Street | 778856.00 | $155.50M | 3.9% | 2026-03-31 |
| Nomura | 687667.00 | $137.29M | 3.4% | 2026-03-31 |
| FMR (Fidelity) | 596127.00 | $119.02M | 3.0% | 2026-03-31 |
| Franklin Resources | 573177.00 | $114.43M | 2.9% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-08-12 |
Back to LGND overview · LGND earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.